IMPROVING ACCESS

AUTHORIZED GENERICS

Enabling more patients to access therapy

Asegua Therapeutics LLC, an affiliate of Gilead Sciences, is committed to expanding access for your patients.

The authorized generic of EPCLUSA® (sofosbuvir/velpatasvir) and the authorized generic of HARVONI® (ledipasvir/sofosbuvir) provide patients with therapeutically equivalent options to the brand-name products at a lower list price and help ensure that prescribing decisions remain in your hands.

Please see full Prescribing Information for sofosbuvir/velpatasvir and ledipasvir/sofosbuvir, including BOXED WARNING.

This information is intended for US healthcare providers only.

ASEGUA and the ASEGUA logo are trademarks of Asegua Therapeutics LLC. EPCLUSA, HARVONI, SUPPORT PATH and GILEAD are trademarks of Gilead Sciences, Inc., or one of its related companies and are used by permission.

©2019 Asegua Therapeutics LLC. All rights reserved. AGPP0017 08/19

Asegua Therapeutics LLC is an affiliate of Gilead Sciences, Inc.